ClinicalTrials.Veeva

Menu

Incidence of Dyschromatopsia in Glaucoma

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Completed

Conditions

Glaucoma

Treatments

Procedure: Color Vision Test

Study type

Observational

Funder types

Other

Identifiers

NCT02966678
Dyschromatopsia

Details and patient eligibility

About

Incidence of dyschromatopsia

Full description

Incidence of dyschromatopsia should be elevated in glaucoma compared to a healthy control population. However, the actual incidence rate is not investigated.

Enrollment

100 patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosis of glaucoma
  • age between 18 and 99 years old
  • best corrected visual acuity(BCVA) > 0.2 (decimal Snellen)

Exclusion criteria

  • age < 18 yo
  • BCVA < 0.2
  • known dyschromatopsia
  • known corneal disease
  • St.p. corneal surgeries
  • macula disease
  • history of medication use that can influence color vision (e.g. hydroxychloroquine)

Trial design

100 participants in 1 patient group

Glaucoma
Description:
Patients with a diagnosis of glaucoma will undergo color vision test
Treatment:
Procedure: Color Vision Test

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems